Table 1. Baseline patient characteristics.

Characteristic
Age, years
Median	60
Range	33–76
Sex, number (%)
Male	9 (50%)
Female	9 (50%)
Race, number (%)
White	16 (89%)
Hispanic	1 (6%)
African-American	1 (6%)
ECOG performance status
0	5 (28%)
1	13 (72%)
Disease stage
Locally advanced	1 (6%)
Metastatic	17 (94%)
Prior therapy
Chemotherapy	16 (89%)
Radiotherapy	6 (33%)
Pancreaticoduodenectomy	5 (28%)
Prior number of chemotherapy regimens
0	2 (11%)
1	3 (17%)
2 or more	13 (72%)
Total number of target lesions
1	1 (6%)
2	4 (22%)
3	9 (50%)
>= 4	4 (22%)
BRCA 1/2 mutation status
Positive	2 (11%)
Unknown	16 (89%)
Negative	0